Safety and efficacy of nivolumab in Japanese patients with malignant melanoma: An interim analysis of a postmarketing surveillance-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Safety and efficacy of nivolumab in Japanese patients with malignant melanoma: An interim analysis of a postmarketing surveillance

Published:2018-02-20 Issue:4 Volume:45 Page:408-415
ISSN:0385-2407
Container-title:The Journal of Dermatology
language:en
Short-container-title:J Dermatol

Author:

Kiyohara Yoshio¹^ORCID,Uhara Hisashi²,Ito Yoshihiko³,Matsumoto Noritake³,Tsuchida Tetsuya⁴,Yamazaki Naoya⁵^ORCID

Affiliation:

1. Dermatology Division; Shizuoka Cancer Center Hospital; Shizuoka Japan

2. Department of Dermatology; Sapporo Medical University School of Medicine; Sapporo Japan

3. Pharmacovigilance Division; Ono Pharmaceutical; Osaka Japan

4. Department of Dermatology; Saitama Medical University; Saitama Japan

5. Department of Dermatologic Oncology; National Cancer Center Hospital; Tokyo Japan

Funder

Ono Pharmaceutical Company

Bristol-Myers Squibb

Publisher

Wiley

Subject

Dermatology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/1346-8138.14227/fullpdf

Reference23 articles.

1. Epidemiology of Skin Cancer in Japan;Nishi;Journal of Tumor,2016

2. Statistical profiles of malignant melanoma and other skin cancers in Japan: 2007 update;Ishihara;Int J Clin Oncol,2008

3. Nivolumab: a review of its use in patients with malignant melanoma;Deeks;Drugs,2014

4. Safety, activity, and immune correlates of anti-PD-1 antibody in cancer;Topalian;N Engl J Med,2012

5. Survival, durable tumor remission, and long-term safety in patients with advanced melanoma receiving nivolumab;Topalian;J Clin Oncol,2014

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Management of liver and gastrointestinal toxicity induced by immune checkpoint inhibitors: Position statement of the AEEH–AEG–SEPD–SEOM–GETECCU;Gastroenterología y Hepatología;2024-04

2. Management of liver and gastrointestinal toxicity induced by immune checkpoint inhibitors: Position statement of the AEEH–AEG–SEPD–SEOM–GETECCU;Gastroenterología y Hepatología (English Edition);2024-04

3. Management of liver and gastrointestinal toxicity induced by immune checkpoint inhibitors: Position statement of the AEEH-AEG-SEPD-SEOM-GETECCU;Revista Española de Enfermedades Digestivas;2024

4. Immunotherapy for mucosal melanoma;Oncology and Translational Medicine;2023-12

5. Immune checkpoint inhibitor‐based therapy for advanced acral and mucosal melanoma;Experimental Dermatology;2022-12-16

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3